Functional role of extracellular signal-regulated kinase activation and c-Jun induction in phorbol ester-induced promoter activation of human 12(S)-lipoxygenase gene

J Biomed Sci. 2002 Mar-Apr;9(2):156-65. doi: 10.1007/BF02256027.

Abstract

The functional role of mitogen-activated protein kinase (MAPK) signaling and c-Jun induction in phorbol 12-myristate 13-acetate (PMA)-induced human 12(S)-lipoxygenase gene expression was studied in human epidermoid carcinoma A431 cells. Among the family of MAPK, PMA only increased the activity of extracellular signal-regulated kinase (ERK). Treatment of cells with PD98059, which is an inhibitor of mitogen-activated protein kinase kinase (MEK), decreased the PMA-induced expression of 12(S)-lipoxygenase. Transfection of cells with Ras, Raf and ERK2 dominant negative mutants inhibited the PMA-induced promoter activation of the 12(S)-lipoxygenase gene in all cases. PMA-induced expression of c-Jun was inhibited by pretreatment with PD98059. Following treatment with PMA, the interaction between c-Jun and simian virus 40 promoter factor 1 (Sp1) in cells increased with time. Enhancement of binding between the c-Jun-Sp1 complex and the Sp1 oligonucleotide was observed in cells treated with PMA, suggesting the possible interaction of c-Jun-Sp1 with GC-rich binding sites in the gene promoter. These results indicate that PMA treatment induced ERK activation mainly through the Raf-MEK-ERK signaling pathway following induction of c-Jun expression, and the formation of the c-Jun-Sp1 complex. Finally, PMA activated the promoter activity of the 12(S)-lipoxygenase gene in cells overexpressing protein kinase C (PKC)delta but not PKCalpha, indicating that PKCdelta played the functional role in mediating the gene activation of 12(S)-lipoxygenase induced by PMA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Enzyme Activation / physiology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Humans
  • Isoenzymes / physiology
  • Lipoxygenase / drug effects
  • Lipoxygenase / genetics*
  • MAP Kinase Kinase Kinase 1*
  • MAP Kinase Signaling System
  • Mitogen-Activated Protein Kinases / metabolism
  • Mitogen-Activated Protein Kinases / physiology*
  • Promoter Regions, Genetic / drug effects*
  • Promoter Regions, Genetic / physiology
  • Protein Binding
  • Protein Kinase C / physiology
  • Protein Kinase C-delta
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins c-jun / metabolism
  • Proto-Oncogene Proteins c-jun / physiology*
  • Proto-Oncogene Proteins c-raf / metabolism
  • Sp1 Transcription Factor / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Transcriptional Activation
  • Tumor Cells, Cultured

Substances

  • Isoenzymes
  • Proto-Oncogene Proteins c-jun
  • Sp1 Transcription Factor
  • Lipoxygenase
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-raf
  • PRKCD protein, human
  • Protein Kinase C
  • Protein Kinase C-delta
  • Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinase 1
  • MAP3K1 protein, human
  • Tetradecanoylphorbol Acetate